Anatomy of a Mushroom
Once again based on experience, I’m confident that many of the folks who will try psilocybin in future, because of all the favorable publicity, will fall into those ‘excluded’ categories.
Read MoreSelect Page
Posted by C. Scott McMillin | Nov 9, 2023 | Addictive Substances | 0 |
Once again based on experience, I’m confident that many of the folks who will try psilocybin in future, because of all the favorable publicity, will fall into those ‘excluded’ categories.
Read MorePosted by C. Scott McMillin | Nov 6, 2023 | Addiction | 0 |
If we conceive of addiction as a disease, Perry would represent those most vulnerable to it. Very little actual exposure to substances would be enough to trigger that pathology.
Read MorePosted by C. Scott McMillin | Nov 2, 2023 | Public Health | 0 |
CDC claims that 1 in 5 drug overdoses in 2020 – or 20% — involved people in those two sectors alone. Something to think about.
Read MorePosted by C. Scott McMillin | Oct 30, 2023 | Addictive Substances | 0 |
Unfortunately, adulterating fentanyl with xylazine makes naloxone substantially less effective in terms of reviving an overdose victim.
Read MorePosted by C. Scott McMillin | Oct 26, 2023 | In the News | 0 |
But, his lawyer reminds us, we shouldn’t forget that his client is ‘only’ 25 years old. Not only that, the client reportedly has assured his attorney that “…I promise you, I’m not a bad person.”
Read More